Cardiovascular disease is prevalent in the Tropics, severely limiting the quality of life of sufferers and placing a heavy strain on ill-equipped health systems. AITHM research aims to reduce the burden of such diseases through strengthening health systems, building workforce capacity and developing effective therapies designed to make a significant difference both at an individual and community level. Research led by Professor Jonathan Golledge and the team at the Queensland Research Centre for Peripheral Vascular Disease (QRCPVD) is investigating potential drug and behavioural therapies to effectively treat patients suffering from Peripheral Artery Disease (PAD) and AAA.